Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion type Assertion NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_head.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion description "[These vaccines used the attenuated fowlpox strain FP9 and the MVA recombinant for either of 2 preerythrocytic malaria antigens, multiple preerythrocytic-stage epitopes joined with the preerythrocytic-stage antigen TRAP (ME-TRAP) and the circumsporozoite protein (CS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_provenance.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion evidence source_evidence_literature NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_provenance.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion SIO_000772 16575727 NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_provenance.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion wasDerivedFrom befree-20140225 NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_provenance.
- NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_assertion wasGeneratedBy ECO_0000203 NP526921.RAFEbxASb1lypc3Z_6oUgHHHg6fd_jwcoM4XVeipAplfA130_provenance.